BY HANK REICHMAN Let’s face it, the pharmaceutical industry has one heck of an image problem.  Even if it is recognized that the notorious and now-indicted Martin Shkreli, who raised the cost of a life-saving pill from $13.50 to $750, was really an exception, price-gouging and the accumulation of excessive profit are charges regularly and…